UT Southwestern explains graft-versus-host disease (GVHD), a potentially serious complication that can occur after an allogeneic stem cell or bone marrow transplant.
A historic stem cell transplant at UT Southwestern Medical Center saved Chuck Dandridge's life. A decade later, he is advocating for more people to participate in bone marrow transplant clinical trials like he did.
Cardiac amyloidosis was once considered untreatable. Now, we have effective treatments, less invasive diagnostic tests, and a growing body of research in this complex disease.
As new CAR T-cell therapies are being approved to treat certain cancers, UT Southwestern explains how its team is working to further revolutionize treatment for more cancer patients.
A new, FDA-approved four-drug combo for AL amyloidosis is improving longevity and quality of life dramatically. UT Southwestern discusses how the medication and a multidisciplinary team of experts can give patients longer, healthier lives.
